Insiders who reported open-market trades in the last 12 months at the companies Grant Pickering files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Jim Wassil - $3.12M in PCVX purchases and sales in the last 12 months
Elvia Cowan - $2.08M in PCVX purchases and sales in the last 12 months
Andrew Guggenhime - $1.64M in PCVX purchases and sales in the last 12 months
Grant Pickering is a corporate insider, tracked as CHIEF EXECUTIVE OFFICER, Director of Vaxcyte, Inc. (PCVX). InsiderAlpha holds 21 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Grant Pickering submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Grant Pickering been buying or selling stock?
Recorded transactions: 0 open-market purchases and 54 open-market sales ($14.15M) across all tracked filings.
Grant Pickering is CHIEF EXECUTIVE OFFICER, Director of Vaxcyte, Inc. (PCVX). 21 SEC Form 4 filings on record going back to 2024, most recently on 9 September 2026. Most recent open-market trade: sold $21K of PCVX on 28 July 2026. Lifetime open-market sales: $14.15M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Grant Pickering.
InsiderAlpha's records for Grant Pickering go back to 2024: 21 primary Form 4 filings, an average of 7.0 per year. 70 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
